The hypothalamus and neuropsychiatric disorders: psychiatry meets microscopy

[1]  K. Schiltz,et al.  Glucose homeostasis in major depression and schizophrenia: a comparison among drug-naïve first-episode patients , 2019, European Archives of Psychiatry and Clinical Neuroscience.

[2]  B. Bogerts,et al.  Postmortem studies indicate altered cell chemical composition of the suprachiasmatic nucleus in mood disorders , 2018, European Archives of Psychiatry and Clinical Neuroscience.

[3]  E. Seifritz,et al.  Anterior cingulate volume predicts response to psychotherapy and functional connectivity with the inferior parietal cortex in major depressive disorder , 2018, European Neuropsychopharmacology.

[4]  Jinhui Wang,et al.  Altered Volume and Functional Connectivity of the Habenula in Schizophrenia , 2017, Front. Hum. Neurosci..

[5]  A. Cleare,et al.  Hypothalamic-pituitary-adrenal (HPA) axis functioning as predictor of antidepressant response–Meta-analysis , 2017, Neuroscience & Biobehavioral Reviews.

[6]  C. McClung,et al.  Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus , 2017, Neural plasticity.

[7]  S. Nakagawa,et al.  Neural basis of major depressive disorder: Beyond monoamine hypothesis , 2017, Psychiatry and clinical neurosciences.

[8]  R. de Oliveira-Souza,et al.  The hypothalamus at the crossroads of psychopathology and neurosurgery. , 2017, Neurosurgical focus.

[9]  Ji-Hong Liu,et al.  An astroglial basis of major depressive disorder? An overview , 2017, Glia.

[10]  B. Bogerts,et al.  Insulin-regulated aminopeptidase immunoreactivity is abundantly present in human hypothalamus and posterior pituitary gland, with reduced expression in paraventricular and suprachiasmatic neurons in chronic schizophrenia , 2017, European Archives of Psychiatry and Clinical Neuroscience.

[11]  D. Swaab,et al.  Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression , 2017, Brain Structure and Function.

[12]  J. Ribeiro,et al.  Depression and psychodynamic psychotherapy , 2017, Revista brasileira de psiquiatria.

[13]  S. Bouret.  Development of Hypothalamic Circuits That Control Food Intake and Energy Balance , 2017 .

[14]  Yuanyuan Xie,et al.  Development of the hypothalamus: conservation, modification and innovation , 2017, Development.

[15]  D. Swaab,et al.  Sexually Dimorphic Changes of Hypocretin (Orexin) in Depression , 2017, EBioMedicine.

[16]  J. Remes,et al.  Long‐term antipsychotic use and brain changes in schizophrenia – a systematic review and meta‐analysis , 2017, Human psychopharmacology.

[17]  Z. Jankowski,et al.  Microglia in the dorsal raphe nucleus plays a potential role in both suicide facilitation and prevention in affective disorders , 2017, European Archives of Psychiatry and Clinical Neuroscience.

[18]  R. Cui,et al.  The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex , 2017, Neural plasticity.

[19]  P. Falkai,et al.  News from the graveyard: Neuropathological research on schizophrenia is alive and productive , 2016, Schizophrenia Research.

[20]  J. Savitz,et al.  Neuropathology of mood disorders: do we see the stigmata of inflammation? , 2016, Translational psychiatry.

[21]  C. Sommer,et al.  Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: A post-mortem study , 2016, Schizophrenia Research.

[22]  Y. Kakinuma,et al.  Loss of dopaminergic neurons occurs in the ventral tegmental area and hypothalamus of rats following chronic stress: Possible pathogenetic loci for depression involved in Parkinson's disease , 2016, Neuroscience Research.

[23]  M. Berger,et al.  Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis , 2016, Neuroscience & Biobehavioral Reviews.

[24]  T. Schneider-Axmann,et al.  Decreased Oligodendrocyte and Neuron Number in Anterior Hippocampal Areas and the Entire Hippocampus in Schizophrenia: A Stereological Postmortem Study. , 2016, Schizophrenia bulletin.

[25]  P Hagmann,et al.  Impaired fornix–hippocampus integrity is linked to peripheral glutathione peroxidase in early psychosis , 2016, Translational Psychiatry.

[26]  P. Xie,et al.  Hypothalamic Proteomic Analysis Reveals Dysregulation of Glutamate Balance and Energy Metabolism in a Mouse Model of Chronic Mild Stress-Induced Depression , 2016, Neurochemical Research.

[27]  N. Parizad,et al.  The Relationship Between Depression and Metabolic Syndrome: Systematic Review and Meta-Analysis Study , 2016, Iranian Red Crescent medical journal.

[28]  J. Lieberman,et al.  Association of orexin receptor polymorphisms with antipsychotic-induced weight gain , 2016, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[29]  S. Ogawa,et al.  Reproductive Neuroendocrine Pathways of Social Behavior , 2016, Front. Endocrinol..

[30]  A. Jaggi,et al.  An Integrative Review on Role and Mechanisms of Ghrelin in Stress, Anxiety and Depression. , 2016, Current drug targets.

[31]  T. Horvath,et al.  Metabolism and Mental Illness. , 2016, Trends in molecular medicine.

[32]  S. Heringa,et al.  Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review , 2015, Schizophrenia Research.

[33]  C. H. Summers,et al.  Evidence for the role of corticotropin-releasing factor in major depressive disorder , 2015, Neuroscience & Biobehavioral Reviews.

[34]  H. Zhao,et al.  Early life adversity induced third ventricular enlargement in young adult male patients suffered from major depressive disorder: a study of brain morphology. , 2015, Folia morphologica.

[35]  J. Irazusta,et al.  Plasma peptidases as prognostic biomarkers in patients with first-episode psychosis , 2015, Psychiatry Research.

[36]  P. Andrews,et al.  Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response , 2015, Neuroscience & Biobehavioral Reviews.

[37]  B. Bogerts,et al.  Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy , 2015, Schizophrenia Research.

[38]  C. Hölscher,et al.  Increased number of orexin/hypocretin neurons with high and prolonged external stress-induced depression , 2014, Behavioural Brain Research.

[39]  D. Atkinson,et al.  Schizophrenia: overview and treatment options. , 2014, P & T : a peer-reviewed journal for formulary management.

[40]  A. Bao,et al.  Nitric oxide synthase and nitric oxide alterations in chronically stressed rats: A model for nitric oxide in major depressive disorder , 2014, Psychoneuroendocrinology.

[41]  E. Drews,et al.  Enkephalin knockout male mice are resistant to chronic mild stress , 2014, Genes, brain, and behavior.

[42]  R. Rajkumar.  Prolactin and Psychopathology in Schizophrenia: A Literature Review and Reappraisal , 2014, Schizophrenia research and treatment.

[43]  B. Bogerts,et al.  Volumetric analysis of the hypothalamus, amygdala and hippocampus in non-suicidal and suicidal mood disorder patients--a post-mortem study. , 2013, CNS & neurological disorders drug targets.

[44]  G. Rajkowska,et al.  Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. , 2013, Current drug targets.

[45]  R. Kahn,et al.  Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. , 2013, Schizophrenia bulletin.

[46]  P. Guest,et al.  Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[47]  J. Wiltfang,et al.  Structural brain alterations associated with schizophrenia preceded by conduct disorder: a common and distinct subtype of schizophrenia? , 2013, Schizophrenia bulletin.

[48]  B. Bogerts,et al.  Some notes on insulin-regulated aminopeptidase in depression. , 2013, The international journal of neuropsychopharmacology.

[49]  B. Bogerts,et al.  Increased nuclear Olig1-expression in the pregenual anterior cingulate white matter of patients with major depression: a regenerative attempt to compensate oligodendrocyte loss? , 2013, Journal of psychiatric research.

[50]  M. Olive,et al.  Neuropeptide systems and schizophrenia. , 2013, CNS & neurological disorders drug targets.

[51]  D. Swaab,et al.  Reduced GAD(65/67) immunoreactivity in the hypothalamic paraventricular nucleus in depression: a postmortem study. , 2013, Journal of affective disorders.

[52]  F. Scheer,et al.  Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression. , 2013, Journal of affective disorders.

[53]  Y. Michotte,et al.  Antidepressant-like effects of oxytocin in mice are dependent on the presence of insulin-regulated aminopeptidase. , 2013, The international journal of neuropsychopharmacology.

[54]  V. Mondelli,et al.  A systematic review of the activity of the hypothalamic–pituitary–adrenal axis in first episode psychosis , 2013, Psychoneuroendocrinology.

[55]  D. Swaab,et al.  Unaltered histaminergic system in depression: a postmortem study. , 2013, Journal of affective disorders.

[56]  Y. Goumon,et al.  Endogenous morphine and its metabolites in mammals: History, synthesis, localization and perspectives , 2013, Neuroscience.

[57]  R. Toni,et al.  Functional Anatomy of the Hypothalamus and Pituitary , 2013 .

[58]  A. Beltramello,et al.  Enlarged hypothalamic volumes in schizophrenia , 2012, Psychiatry Research: Neuroimaging.

[59]  S. Stahl,et al.  Glutamate Neurocircuitry: Theoretical Underpinnings in Schizophrenia , 2012, Front. Pharmacol..

[60]  B. Bogerts,et al.  Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis , 2012, European Archives of Psychiatry and Clinical Neuroscience.

[61]  R. Murray,et al.  Hypothalamic–pituitary–adrenal axis and clinical symptoms in first-episode psychosis , 2012, Psychoneuroendocrinology.

[62]  Vaughan J. Carr,et al.  Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia , 2012, Neuroscience & Biobehavioral Reviews.

[63]  M. Azevedo,et al.  Revisiting Thyroid Hormones in Schizophrenia , 2012, Journal of thyroid research.

[64]  R. Kahn,et al.  Hypothalamus and pituitary volume in schizophrenia: a structural MRI study. , 2012, The international journal of neuropsychopharmacology.

[65]  B. Bogerts,et al.  A postmortem assessment of mammillary body volume, neuronal number and densities, and fornix volume in subjects with mood disorders , 2012, European Archives of Psychiatry and Clinical Neuroscience.

[66]  R. Turner,et al.  Structural studies of the hypothalamus and its nuclei in mood disorders , 2012, Psychiatry Research: Neuroimaging.

[67]  M. Banasr,et al.  Cell atrophy and loss in depression: reversal by antidepressant treatment. , 2011, Current opinion in cell biology.

[68]  P. Falkai,et al.  Schizophrenia as a disorder of disconnectivity , 2011, European Archives of Psychiatry and Clinical Neuroscience.

[69]  Michael D. Spain,et al.  Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia , 2011, Psychoneuroendocrinology.

[70]  V. Steen,et al.  Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation , 2011, PloS one.

[71]  A. Bao,et al.  Corticotropin-Releasing Hormone, Glutamate, and γ-Aminobutyric Acid in Depression , 2011, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[72]  T. Dinan,et al.  A systematic review of hypothalamic–pituitary–adrenal axis function in schizophrenia: implications for mortality , 2010, Journal of psychopharmacology.

[73]  B. Bogerts,et al.  The Hypothalamus in Schizophrenia Research: No Longer a Wallflower Existence~!2009-12-09~!2010-02-07~!2010-08-09~! , 2010 .

[74]  Edward T Bullmore,et al.  Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness. , 2010, Schizophrenia bulletin.

[75]  C. Hendrie,et al.  Depression as an evolutionary adaptation: anatomical organisation around the third ventricle. , 2010, Medical hypotheses.

[76]  A. Sawa,et al.  Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models. , 2010, Schizophrenia bulletin.

[77]  B. Bogerts,et al.  Schizophrenia, sleep disturbances and the suprachiasmatic nucleus: reduced nitric oxide synthase may matter. , 2010, Medical hypotheses.

[78]  G. Yadid,et al.  The β-Endorphin Role in Stress-Related Psychiatric Disorders , 2009 .

[79]  R. Lanius,et al.  The role of β-endorphin in the pathophysiology of major depression , 2009, Neuropeptides.

[80]  J. Bundzikova,et al.  Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry , 2009, Journal of neuroscience research.

[81]  B. Bogerts,et al.  Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia. , 2009, Journal of psychiatric research.

[82]  Jordan Grafman,et al.  The functional neuroanatomy of depression: Distinct roles for ventromedial and dorsolateral prefrontal cortex , 2009, Behavioural Brain Research.

[83]  B. Bogerts,et al.  Evidence for structural abnormalities of the human habenular complex in affective disorders but not in schizophrenia , 2009, Psychological Medicine.

[84]  B. Bogerts,et al.  Cathepsin K generates enkephalin from β-endorphin: A new mechanism with possible relevance for schizophrenia , 2009, Neurochemistry International.

[85]  Z. Chemali.  Long-Term Antipsychotic Use in Alzheimer Disease , 2009 .

[86]  T. Schneider-Axmann,et al.  Stereologic investigation of the posterior part of the hippocampus in schizophrenia , 2009, Acta Neuropathologica.

[87]  C. Schwarzer,et al.  Prodynorphin-Derived Peptides Are Critical Modulators of Anxiety and Regulate Neurochemistry and Corticosterone , 2009, Neuropsychopharmacology.

[88]  B. Bogerts,et al.  The volumes of the fornix in schizophrenia and affective disorders: A post-mortem study , 2008, Psychiatry Research: Neuroimaging.

[89]  E. Bullmore,et al.  The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. , 2008, The American journal of psychiatry.

[90]  D F Swaab,et al.  Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances , 2008, Molecular Psychiatry.

[91]  E. Frank,et al.  The vasopressin system--from antidiuresis to psychopathology. , 2008, European journal of pharmacology.

[92]  B. Bogerts,et al.  Beacon-like/ubiquitin-5-like immunoreactivity is highly expressed in human hypothalamus and increased in haloperidol-treated schizophrenics and a rat model of schizophrenia , 2008, Psychoneuroendocrinology.

[93]  Hilleke E. Hulshoff Pol,et al.  Hypothalamus volume in twin pairs discordant for schizophrenia , 2008, European Neuropsychopharmacology.

[94]  D. Marazziti,et al.  The role of oxytocin in neuropsychiatric disorders. , 2008, Current medicinal chemistry.

[95]  M. Engelmann,et al.  Neuronal nitric oxide synthase gene inactivation reduces the expression of vasopressin in the hypothalamic paraventricular nucleus and of catecholamine biosynthetic enzymes in the adrenal gland of the mouse , 2008, Stress.

[96]  S. Keller,et al.  Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP. , 2007, American journal of physiology. Endocrinology and metabolism.

[97]  A. Giusti-Paiva,et al.  Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats , 2007, Experimental physiology.

[98]  N. Uranova,et al.  The role of oligodendrocyte pathology in schizophrenia. , 2007, The international journal of neuropsychopharmacology.

[99]  N. Makris,et al.  Hypothalamic Abnormalities in Schizophrenia: Sex Effects and Genetic Vulnerability , 2007, Biological Psychiatry.

[100]  B. Bogerts,et al.  Cathepsin K and schizophrenia , 2007, Synapse.

[101]  D. Swaab,et al.  Hypothalamic oxytocin mRNA expression and melancholic depression , 2007, Molecular Psychiatry.

[102]  B. Bogerts,et al.  Strongly Reduced Number of Parvalbumin‐Immunoreactive Projection Neurons in the Mammillary Bodies in Schizophrenia , 2007, Annals of the New York Academy of Sciences.

[103]  D. Swaab,et al.  Increased Arginine Vasopressin mRNA Expression in the Human Hypothalamus in Depression: A Preliminary Report , 2006, Biological Psychiatry.

[104]  M. Keshavan,et al.  Pituitary Volume in Treatment-Naïve Pediatric Major Depressive Disorder , 2006, Biological Psychiatry.

[105]  K. Elliott,et al.  Association of Genetic Variation Within UBL5 with Phenotypes of Metabolic Syndrome , 2006, Human Biology: The Official Publication of the American Association of Anthropological Genetics.

[106]  Carl-Fredrik Westin,et al.  Fornix Integrity and Hippocampal Volume in Male Schizophrenic Patients , 2006, Biological Psychiatry.

[107]  K. Lesch,et al.  Neural stem cell proliferation is decreased in schizophrenia, but not in depression , 2006, Molecular Psychiatry.

[108]  D. Swaab,et al.  Absence of a Difference in the Neurosecretory Activity of Supraoptic Nucleus Vasopressin Neurons of Neuroleptic-Treated Schizophrenic Patients , 2006, Neuroendocrinology.

[109]  L. Caregaro,et al.  Disorders of eating behavior: Correlation between hypothalamo-pituitary–thyroid function and psychopathological aspects , 2006, Psychoneuroendocrinology.

[110]  Bernhard Bogerts,et al.  The many faces of nitric oxide in schizophrenia. A review , 2005, Schizophrenia Research.

[111]  B. Bogerts,et al.  Hypothalamic nitric oxide synthase in affective disorder: focus on the suprachiasmatic nucleus. , 2005, Cellular and molecular biology.

[112]  B. Bogerts,et al.  Volume deficits of subcortical nuclei in mood disorders , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[113]  P. Kelly,et al.  Selective Neuron Loss in the Paraventricular Nucleus of Hypothalamus in Patients Suffering from Major Depression and Bipolar Disorder , 2005, Journal of neuropathology and experimental neurology.

[114]  G. Mastorakos,et al.  The Hypothalamic-Pituitary-Adrenal Axis in the Neuroendocrine Regulation of Food Intake and Obesity: The Role of Corticotropin Releasing Hormone , 2004, Nutritional neuroscience.

[115]  B. Bogerts,et al.  Further Immunohistochemical Evidence for Impaired NO Signaling in the Hypothalamus of Depressed Patients , 2002, Annals of the New York Academy of Sciences.

[116]  E. Young,et al.  The hypothalamic-pituitary-gonadal axis in mood disorders. , 2002, Endocrinology and metabolism clinics of North America.

[117]  D. Swaab,et al.  Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. , 2001, Archives of general psychiatry.

[118]  L. Selemon,et al.  Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder , 2001, Biological Psychiatry.

[119]  Ron Kikinis,et al.  A quantitative MR measure of the fornix in schizophrenia , 2001, Schizophrenia Research.

[120]  Paul J. Harrison.  Postmortem studies in schizophrenia , 2000, Dialogues in clinical neuroscience.

[121]  B. Bogerts,et al.  Low and infrequent expression of nitric oxide synthase/NADPH-diaphorase in neurons of the human supraoptic nucleus: a histochemical study , 2000, Journal of Chemical Neuroanatomy.

[122]  T. Sharma,et al.  Third ventricle enlargement and developmental delay in first-episode psychosis: preliminary findings. , 2000, The British journal of psychiatry : the journal of mental science.

[123]  Janine McMillan,et al.  Beacon: A novel gene involved in the regulation of energy balance , 2000, Regulatory Peptides.

[124]  D. Swaab,et al.  Brain alterations in depression , 2000, Acta Neuropsychiatrica.

[125]  A. Altamura,et al.  HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment , 1999, European Neuropsychopharmacology.

[126]  T. Crow,et al.  Fiber content of the fornix in schizophrenia: lack of evidence for a primary limbic encephalopathy. , 1999, The American journal of psychiatry.

[127]  P S Kalra,et al.  Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. , 1999, Endocrine reviews.

[128]  P. Goldman-Rakic,et al.  The reduced neuropil hypothesis: a circuit based model of schizophrenia , 1999, Biological Psychiatry.

[129]  B. Bogerts,et al.  Expression of Hypothalamic Peptides in Mice Lacking Neuronal Nitric Oxide Synthase: Reduced β-END Immunoreactivity in the Arcuate Nucleus , 1998, Neuroendocrinology.

[130]  I. Everall,et al.  Mamillary body abnormalities in schizophrenia , 1998, The Lancet.

[131]  C. Nemeroff.  Structural Brain Alterations in Polysubstance Abusers , 1998 .

[132]  P. Goldman-Rakic,et al.  Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. , 1998, Archives of general psychiatry.

[133]  B. Bogerts,et al.  Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics , 1998, Neuroscience.

[134]  B. Bogerts,et al.  Changes in CSF spaces differ in endogenous and neurotic depression. A planimetric CT scan study. , 1997, Journal of affective disorders.

[135]  D. Swaab,et al.  Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. , 1996, Archives of general psychiatry.

[136]  D F Swaab,et al.  Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. , 1995, The American journal of psychiatry.

[137]  N. Butters,et al.  Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities. , 1995, Archives of general psychiatry.

[138]  J. Palacios,et al.  In situ hybridization for vasopressin mRNA in the human supraoptic and paraventricular nucleus; quantitative aspects of formalin-fixed paraffin-embedded tissue sections as compared to cryostat sections , 1995, Journal of Neuroscience Methods.

[139]  K. A. Kadir,et al.  High Prevalence of Thyroid Function Test Abnormalities in Chronic Schizophrenia , 1994, The Australian and New Zealand journal of psychiatry.

[140]  D. Swaab,et al.  Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. , 1994, Neuroendocrinology.

[141]  P. Emson,et al.  Up-regulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the rat hypothalamo-hypophysial system after chronic salt loading: evidence of a neuromodulatory role of nitric oxide in arginine vasopressin and oxytocin secretion. , 1994, Endocrinology.

[142]  M. Timsit-Berthier,et al.  Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics , 1992, Psychoneuroendocrinology.

[143]  N. Kowall,et al.  NADPH diaphorase histochemistry of the human hypothalamus , 1991, Neuroscience.

[144]  R. Ekman,et al.  Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics , 1991, Acta psychiatrica Scandinavica.

[145]  Darrell M. Wilson,et al.  Growth hormone response to growth hormone releasing hormone in depression and schizophrenia , 1990, Psychiatry Research.

[146]  J. Kleinman,et al.  Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients , 1987, Psychiatry Research.

[147]  H. Emrich,et al.  Dopamine and the action of opiates: A reevaluation of the dopamine hypothesis of schizophrenia with special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia , 1985, Biological Psychiatry.

[148]  C. Golden,et al.  Ventricular enlargement in major depression , 1983, Psychiatry Research.

[149]  O. Hornykiewicz,et al.  Norepinephrine in chronic paranoid schizophrenia: above-normal levels in limbic forebrain. , 1978, Science.

[150]  M. Kedinger,et al.  Survival of chick embryonic organs submitted to high hydrostatic pressures. , 1973, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[151]  Kraines Sh.  Manic depressive syndrome: a physiologic disease. II. , 1966 .

[152]  S. H. Kraines.  The physiologic basis of the manic-depressive illness: a theory. , 1957, The American journal of psychiatry.

[153]  B. Hechst.  Zur Histopathologie der Schizophrenie mit besonderer Berücksichtigung der Ausbreitung des Prozessses , 1931 .

[154]  W. K. Simmons,et al.  Depression and obesity: evidence of shared biological mechanisms , 2018, Molecular Psychiatry.

[155]  A. Riecher-Rössler.  Oestrogens, prolactin, hypothalamic-pituitary-gonadal axis, and schizophrenic psychoses. , 2017, The lancet. Psychiatry.

[156]  A. Cleare,et al.  HPA axis functioning predicts antidepressant response Hypothalamic-pituitary-adrenal ( HPA ) axis functioning as predictor of antidepressant response – meta-analysis , 2017 .

[157]  M. Kanehisa,et al.  The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after discharge. , 2013, Neuro endocrinology letters.

[158]  P. Kreczmański.  Neuropathology of schizophrenia : a new vistas , 2009 .

[159]  B. Bogerts,et al.  Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. , 2008, Journal of psychiatric research.

[160]  Anneke Alkemade,et al.  Hypothalamic thyroid hormone feedback in health and disease. , 2006, Progress in brain research.

[161]  B. Bogerts,et al.  The diencephalon in schizophrenia: Evidence for reduced thickness of the periventricular grey matter , 2004, European archives of psychiatry and neurological sciences.

[162]  THE CHANGES OF HYPOTHALAMIC NUCLEI IN SCHIZOPHRENIA , 2003 .

[163]  J. Macher,et al.  Disturbances in hypothalamo pituitary adrenal and thyroid axis identify different sleep EEG patterns in major depressed patients. , 2003, Journal of psychiatric research.

[164]  B. Bogerts,et al.  Fewer beta-endorphin expressing arcuate nucleus neurons and reduced beta-endorphinergic innervation of paraventricular neurons in schizophrenics and patients with depression. , 2002, Cellular and molecular biology.

[165]  D. Lewis,et al.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.

[166]  S. Heckers,et al.  Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. , 1997, Schizophrenia bulletin.

[167]  J. K. Mai,et al.  Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. , 1993, Journal fur Hirnforschung.

[168]  J. Burbach,et al.  Increased concentration of alpha- and gamma-endorphin in post mortem hypothalamic tissue of schizophrenic patients. , 1988, Life sciences.

[169]  J. Burbach,et al.  Increased concentration of α- and γ-endorphin in post mortem hypothalamic tissue of schizophrenic patients , 1988 .

[170]  P. Seeburg,et al.  The mammalian GnRH gene and its pivotal role in reproduction. , 1987, Recent progress in hormone research.

[171]  C. Nemeroff,et al.  Somatostatin and Behavior: Preclinical and Clinical Studies , 1987 .

[172]  J. Haracz.  The dopamine hypothesis: an overview of studies with schizophrenic patients. , 1982, Schizophrenia bulletin.

[173]  W. Vale,et al.  Regulatory peptides of the hypothalamus. , 1977, Annual review of physiology.

[174]  A. Lohman,et al.  Structure and fiber connections of the hypothalamus in mammals. , 1974, Progress in brain research.

[175]  E. Gerber.  [Histopathology of neurosecretory nuclei in different types of schizophrenia]. , 1966, Vestnik Akademii meditsinskikh nauk SSSR.

[176]  S. H. Kraines.  Manic depressive syndrome: a physiologic disease. , 1966, Diseases of the nervous system.